In a unanimous ruling, Justice Jackson said drugmakers weren’t violating the law by truthfully describing a generic drug as equivalent to a brand-name competitor.
WASHINGTON (CN) — The Supreme Court on Thursday ruled that a generic drugmaker didn’t overstep when advertising its product as a substitute for a brand-name pharmaceutical treating heart disease.
Additional Reads
Read Full Article: https://www.courthousenews.com/justices-protect-generic-drugmaker-from-patent-infringement-liability/
